Developing a vaccine to fight Candida auris infections
Task V31: Process Development for Panfungal Vaccine
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from a serious fungal infection called Candida auris, with hopes of making it safe and effective for future testing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-11202801 on NIH RePORTER |
What this research studies
This research focuses on creating a vaccine to combat Candida auris, a serious fungal infection that poses a significant threat to patients, especially those with weakened immune systems. The project involves planning and optimizing the vaccine's development, ensuring it meets regulatory standards for safety and efficacy. By utilizing advanced manufacturing techniques, the research aims to produce a vaccine that can be tested in early clinical trials, potentially leading to effective prevention strategies against this dangerous pathogen.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for Candida auris infections, such as those with compromised immune systems or those undergoing invasive medical procedures.
Not a fit: Patients who are not at risk for fungal infections or those with healthy immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new vaccine that significantly reduces the incidence of Candida auris infections in vulnerable populations.
How similar studies have performed: Other research has shown promise in developing vaccines against similar infectious diseases, indicating potential for success in this area.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.